Qube Research & Technologies (QRT)’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.7M | Sell |
296,405
-1,664,313
| -85% | -$60M | 0.01% | 911 |
|
|
2025
Q1 | $61M | Buy |
1,960,718
+371,221
| +23% | +$11.6M | 0.07% | 247 |
|
|
2024
Q4 | $40.5M | Sell |
1,589,497
-345,476
| -18% | -$8.81M | 0.05% | 342 |
|
|
2024
Q3 | $54.7M | Buy |
1,934,973
+255,838
| +15% | +$7.24M | 0.08% | 244 |
|
|
2024
Q2 | $44.3M | Buy |
1,679,135
+908,455
| +118% | +$24M | 0.07% | 272 |
|
|
2024
Q1 | $23.4M | Sell |
770,680
-1,294,847
| -63% | -$39.3M | 0.04% | 446 |
|
|
2023
Q4 | $58M | Buy |
2,065,527
+354,655
| +21% | +$9.96M | 0.11% | 209 |
|
|
2023
Q3 | $46.4M | Buy |
1,710,872
+531,529
| +45% | +$14.4M | 0.12% | 194 |
|
|
2023
Q2 | $36.3M | Buy |
1,179,343
+750,586
| +175% | +$23.1M | 0.13% | 202 |
|
|
2023
Q1 | $15.4M | Sell |
428,757
-363,288
| -46% | -$13.1M | 0.07% | 293 |
|
|
2022
Q4 | $31.3M | Buy |
792,045
+468,762
| +145% | +$18.5M | 0.17% | 145 |
|
|
2022
Q3 | $13M | Buy |
323,283
+266,953
| +474% | +$10.7M | 0.08% | 329 |
|
|
2022
Q2 | $2.37M | Sell |
56,330
-213,523
| -79% | -$8.98M | 0.02% | 733 |
|
|
2022
Q1 | $10.5M | Buy |
269,853
+211,285
| +361% | +$8.23M | 0.09% | 281 |
|
|
2021
Q4 | $2.33M | Sell |
58,568
-24,636
| -30% | -$982K | 0.02% | 790 |
|
|
2021
Q3 | $3.01M | Sell |
83,204
-3,742
| -4% | -$135K | 0.04% | 557 |
|
|
2021
Q2 | $3.56M | Buy |
+86,946
| New | +$3.56M | 0.04% | 507 |
|
|
2020
Q4 | – | Sell |
-71,728
| Closed | -$3.02M | – | 2139 |
|
|
2020
Q3 | $3.02M | Buy |
+71,728
| New | +$3.02M | 0.04% | 507 |
|